NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 15 / 982

  1. Cannabis Use Prevalence and Trends (2016–2024): Estimating the Impact of Representation Bias in BRFSS Data2026 · Crossref
  2. Cannabis use settings matter: National-level prevalence rates, correlates, and consequences of solitary cannabis use among high school students in Norway.2026 · PubMed
  3. Cannabis Use Transitions During Early Pregnancy2026 · Crossref
  4. Cannabis use, affect and emotion regulation in daily life: A 3‐week experience sampling method study in people who smoke cannabis almost daily2026 · Crossref
  5. Cannabis use, cognitive function and dementia risk in older adults: observational and genetic analyses2026 · Crossref
  6. CANNABIS, ECONOMIA CIRCULAR E TECNOLOGIAS SOCIAIS2026 · Crossref
  7. Cannabis, Extracts, and Individual Phytocannabinoids—All the Same or Substantially Different? A Call for Better Characterization of Cannabis Products2026 · Crossref
  8. Cannabis, Psychedelics, and Other Substance Use to Manage Premenstrual Symptoms: A Survey Study.2026 · PubMed
  9. Cannabis, Religion, and Trust in the Medical Profession: A Cross‐Religious Study of Patients' Attitudes Toward Medical and Recreational Use in Northern Israel2026 · Crossref
  10. Cannabis-associated hyperalgesia and reduced local anesthetic efficacy in oral surgery: A case report.2026 · PubMed
  11. Cannabis-based medicines: On the topic of intoxication.2026 · PubMed
  12. Cannabis-derived food products: a global review of THC exposure, safety and forensic frameworks.2026 · PubMed
  13. Cannabis-Entzug erhöht Risiko einer Einweisung in die psychiatrische Intensivstation2026 · Crossref
  14. Cannabis-related hospitalizations before and after the legalization of recreational cannabis among children and youth in Manitoba, Canada2026 · Crossref
  15. Cannabis-Related Problems, Adverse Events, Clinical Experiences and Barriers to Intervening: Perspectives of Health Care Providers in Washington State2026 · Crossref
  16. Cannabis: from crop to shop—some insights about stability to access quality control2026 · Crossref
  17. Cannabisinduzierte Hyperemesis – selten und tödlich?2026 · Crossref
  18. Capacity Building Through Psychedelic-Assisted Therapy: Navigating Social Determinants of Health.2026 · PubMed
  19. Capillary Electrophoresis Method for Quantification of Naltrexone and Its Major Metabolite 6-β-Naltrexol in Human Plasma.2026 · PubMed
  20. Carbamate-based cannabinoids uncover a conserved lipid-sensing pocket in nociceptive TRPA1 and TRPV1 channels.2026 · PubMed
  21. Carbon farming strategies for mediterranean agriculture: the role of biochar in climate-smart agroecosystems.2026 · PubMed
  22. Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting System2026 · OpenAlex
  23. Cardiac blood phenethylamine as a potential biomarker for post-mortem interval in forensic autopsy cases.2026 · PubMed
  24. Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.2026 · PubMed
  25. Cardiotoxicity of new psychoactive substances – A review of experimental studies and real clinical and forensic cases2026 · Crossref
  26. Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.2026 · PubMed
  27. Cardiovascular Effects of Kratom (Mitragyna speciosa).2026 · PubMed
  28. Cardiovascular health and depression among postpartum women in the United States.2026 · PubMed
  29. Cardiovascular health as an unmet priority in addiction medicine: Implications of recent cardiovascular strategies2026 · Crossref
  30. Cardiovascular health benefits of aerobic exercise training in methamphetamine-dependent male individuals: A randomized controlled trial.2026 · PubMed
  31. Cardiovascular safety of psilocybin in psychiatric practice: a narrative review.2026 · PubMed
  32. Cardiovascular-Kidney-Metabolic Syndrome and Health Risk Behaviors in U.S. Adults.2026 · PubMed
  33. Care access and provision for persons surviving opioid overdose and toxic brain injury, with recommendations to address the unfolding polycrisis.2026 · PubMed
  34. Caregivers’ Experiences of Family-Based Trauma-Informed Interventions for Children with Prenatal Alcohol Exposure2026 · Crossref
  35. Carfentanil in the illicit drug supply: A machine learning approach for trace detection using surface-enhanced Raman spectroscopy.2026 · PubMed
  36. Cartografias da Terra Incógnita: a Filosofia Psicodélica em Céu e Inferno de Aldous Huxley2026 · OpenAlex
  37. Case report: Acamprosate for treatment of volatile hydrocarbon (VHC) inhalant use disorder with comorbid alcohol use disorder2026 · Crossref
  38. Case Report: Amplified psychoanalysis? Psychoanalysis, OCD and MDMA in a clinical case study2026 · Crossref
  39. Case Report: Persistent delusional memories after postoperative delirium in a woman with complex cardiac surgical history2026 · Crossref
  40. Case Report: Pharmacist-Led Induction of Sublingual Buprenorphine/Naloxone for Kratom Use Disorder.2026 · PubMed
  41. Case Report: Reintroduction of winged infusion sets to needle syringe programs - advancing equity in harm reduction2026 · Crossref
  42. Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins2026 · OpenAlex
  43. Case series involving the synthetic cathinones alpha-PHP, alpha-PiHP, MDPHP, and MDPiHP in forensic investigations.2026 · PubMed
  44. Case Series: Simultaneous Use of Long-Acting Injectable Antipsychotics and Vivitrol or Long-Acting Buprenorphine in Dual Diagnosis Patients with Bipolar Disorder and Substance Use Disorders2026 · Crossref
  45. Caste and tobacco use: Decomposing inequalities using Global Adult Tobacco Survey, India2026 · Crossref
  46. Catatonia in an Adolescent: Efficacy of ECT Following Partial Response to Benzodiazepines2026 · Crossref
  47. Catecholaminergic Contributions to Inhibitory Control Following Physical Fatigue: Behavioral and Neurophysiological Findings.2026 · PubMed
  48. Causes of death among people living in prison in Greece: A 9-year retrospective study (2010-2018) at the national prison hospital.2026 · PubMed
  49. Caution before canonisation: a clinical and implementation science perspective on psychedelics2026 · OpenAlex
  50. CBD-Containing Topical Formulation for Localized Pain in Fibromyalgia: A 12-Week Pilot Feasibility Study2026 · Crossref
  51. Celebrity drug display on social media and its influence on youths’ substance abuse in Lagos State, Nigeria2026 · Crossref
  52. Cell-type-specific alkaloid and terpenoid biosynthesis in glandular trichomes: single-cell and spatial transcriptomic perspectives2026 · Crossref
  53. Cellular and Microcircuit Mechanisms of Anesthetic Disruption of Conscious-State Organization.2026 · PubMed
  54. Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation.2026 · PubMed
  55. Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD).2026 · PubMed
  56. Centering the voices of young people who use opioids and youth harm reduction practitioners: insights from an international Youth RISE cohort.2026 · PubMed
  57. Centering Veteran expertise: advancing peer-led harm reduction in the Veterans health administration2026 · Crossref
  58. Central Asian Medicinal Plants as Emerging Sources of Antimicrobial Natural Products Against Multidrug-Resistant Pathogens: A Narrative Review2026 · Crossref
  59. Cerebellar Alteration in Resting-State Functional Connectivity Among Kratom (<i>Mitragyna speciosa</i>) Users: Insights from Functional MRI.2026 · PubMed
  60. Cerebrospinal fluid as a post-mortem toxicological matrix: qualitative reliability and quantitative limitations in a cocaine-positive cases.2026 · PubMed
  61. Cervical Cancer and Sexually Transmitted Infections Screening Among Individuals with a Substance Use Disorder: A Retrospective Cohort Study2026 · Crossref
  62. CFAP58-deficient human sperm show radial spoke-doublet microtubule interface abnormalities and successful fertilization by ICSI.2026 · PubMed
  63. Challenges and benefits of AI in the addiction workforce2026 · Crossref
  64. Challenges and Prospects of Cooperation between the Republic of Uzbekistan and International Actors in Countering New Synthetic Narcotic Substances2026 · Crossref
  65. Challenges for the new regulatory framework of medical Cannabis in Brazil2026 · Crossref
  66. Challenges in Anti-addiction Drug Development: Lost in Translation?2026 · Crossref
  67. Challenges in the interpretation of amphetamine results: differences of reactivity between immunoassay and immunochromatography.2026 · PubMed
  68. Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.2026 · PubMed
  69. Challenges, Legal Aperture and Future Approaches in Handling Sexual Offence Cases in India: A Comprehensive Review2026 · Crossref
  70. Chambers of secrets: how the US Chamber of Commerce advances tobacco industry agendas2026 · Crossref
  71. Change and Antecedents of Cannabis Consumption After the Legalization of Recreational Cannabis in Germany2026 · Crossref
  72. Change of substance-related hospitalisation in adolescents after cannabis legalisation in Thailand in 2022.2026 · PubMed
  73. Changes in activity across the light-dark cycle during ethanol self-administration, extinction, and ethanol cue-induced reinstatement in rats.2026 · PubMed
  74. Changes in adult cannabis use patterns following retail availability in California (2017 to 2024)2026 · Crossref
  75. Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression.2026 · PubMed
  76. Changes in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark2026 · Crossref
  77. Changes in community health worker knowledge and perspectives following opioid overdose prevention and response training.2026 · PubMed
  78. Changes in Community-level Pedestrian Stops Following Overdose Prevention Center Implementation in New York City: An Augmented Synthetic Control Approach.2026 · PubMed
  79. Changes in depression symptom network structure following ketamine treatment in treatment-resistant depression.2026 · PubMed
  80. Changes in gambling behaviour and harm across the adult population, among priority groups, and by population subgroups in Great Britain, 2021-2024: Repeat cross-sectional annual survey.2026 · PubMed
  81. Changes in heroin-related ambulance attendances following the introduction of a medically supervised injecting room in Victoria, Australia.2026 · PubMed
  82. Changes in neuroticism and values after naturalistic use of psychedelics and MDMA: A prospective survey study2026 · OpenAlex
  83. Changes in Symptoms of Cannabis Use Disorder of Ontario Youth Across the COVID-19 Pandemic: A Longitudinal Cohort Study2026 · Crossref
  84. Changes in the Drug Abuse Situation in the Russian Federation and Measures to Combat Illegal Drug Trafficking2026 · Crossref
  85. CHANGES IN THE GLUTATHIONE SYSTEM OF RATS OF DIFFERENT AGES DURING EXPERIMENTAL SCOPOLAMINE-INDUCED NEURODEGENERATE PROCESS: THERAPEUTIC POTENTIAL OF CARBACETAM2026 · Crossref
  86. Changes in tobacco use patterns among students aged 13–15 years in 13 countries: Global Youth Tobacco Survey, 2013–20232026 · Crossref
  87. Changes in trauma symptoms of discrimination after MDMA-assisted psychotherapy for posttraumatic stress disorder.2026 · PubMed
  88. Changes over time in hallucinogen-related emergency department visits in Ontario, Canada.2026 · PubMed
  89. Changing Drug Consumption Patterns Among Clients Attending the Medically Supervised Injecting Centre, Sydney: Implications for Service Provision and Harm Reduction Response2026 · Crossref
  90. Changing Norms, Changing Risks: Adolescent Cannabis Use Surpasses Tobacco in the United States.2026 · PubMed
  91. Changing Patterns of Recent Substance Use in Emerging Adulthood and Their Associations With Cognitive Functions and Mental Health.2026 · PubMed
  92. Changing Patterns of Tobacco use and Psychological Barriers to Tobacco Use Cessation Among Those in Early Remission of Alcohol Dependence: A Cross-sectional Study2026 · Crossref
  93. Changing Perceptions of Risk Reduction Among First Responders: Outcomes of a Training Program in Louisiana2026 · Crossref
  94. Changing the Landscape of Opiate Addiction Treatment - the Impact of Long Acting Injectable Buprenorphine (Buvidal) and the Buvidal Psychological Support Services (BPSS) on the Reduction of Illicit Drug Use2026 · Crossref
  95. Chaplains in Psychedelic Assisted Therapy: Rationale and Competencies.2026 · PubMed
  96. Characterisation of the designer cathinone N-isopropylbutylone by a multi-technique approach and its metabolic profiling and stability assessment using dried matrix spots.2026 · PubMed
  97. Characterising the Beyond 50 Cohort: Preliminary Exploration of Physical and Psychosocial Health Factors and Substance Use Among a Cohort of Community Dwelling Adults Aged 50-70 Years.2026 · PubMed
  98. Characteristic MRI findings of nitrous oxide-induced subacute combined degeneration despite low-normal vitamin B12 levels.2026 · PubMed
  99. Characteristics of adverse reactions to kratom and implementation of harm reduction strategies in a sample of ethnobotanical tea bar patrons in Colorado2026 · Crossref
  100. Characteristics of biocomponents of Amanita muscaria (L.) Lam. fruit bodies collected in the forests of central Poland depending on the tree species, harvest date and weather conditions2026 · Crossref